Digital Transformation Framework Using Secure Distributed Platforms for Clinical Communities, Biomedical Industries, Drug Enterprises, and Public Users

Citra Ayuningtyas , Department of Medical Education, Faculty of Medicine, Universities Gadjah Mada, Yogyakarta, Indonesia
Articles | Open Access

Abstract

Digital transformation in healthcare ecosystems has become a critical enabler for improving interoperability, data-driven decision-making, and patient-centric service delivery across clinical communities, biomedical industries, pharmaceutical enterprises, and public health users. However, existing centralized healthcare information systems suffer from limitations such as data silos, security vulnerabilities, lack of transparency, and inefficiencies in cross-sector collaboration. This paper proposes a conceptual and technical framework for a secure distributed digital transformation platform designed to integrate heterogeneous stakeholders within the biomedical ecosystem.

The proposed framework leverages distributed computing principles, secure data exchange mechanisms, and multi-layered governance structures to enable scalable, privacy-preserving, and efficient biomedical data sharing. Drawing on principles from cyberinfrastructure systems and biomedical informatics, the framework emphasizes interoperability between clinical databases, pharmaceutical research pipelines, and public health information systems (Buetow, 2005; Cannataro et al., 2004). Additionally, the study integrates insights from information diffusion models and public sentiment systems to enhance real-time decision-making and communication efficiency across networks (Xiong et al., 2012; Cha et al., 2010).

The methodology involves a structured architectural design combining distributed ledger-inspired data integrity mechanisms, secure identity management, and modular service orchestration for clinical and industrial applications. The framework is evaluated conceptually through scenario-based analysis, highlighting its applicability in disease surveillance, drug development pipelines, and patient engagement systems.

Findings suggest that secure distributed platforms significantly improve data accessibility, reduce redundancy, and enhance cross-domain collaboration efficiency. However, challenges such as regulatory compliance, computational overhead, and integration complexity remain critical barriers to large-scale adoption.

This study contributes to the growing body of knowledge on biomedical digital ecosystems by proposing a unified transformation model that bridges clinical practice, pharmaceutical innovation, and public health communication. It further provides a foundation for future research in scalable healthcare informatics architectures and secure data-driven biomedical systems.

Keywords

Digital transformation, distributed systems, healthcare informatics, biomedical platforms, data security, clinical networks, clinical networksinteroperability, cyber infrastructure, public health systems

References

AL. McGuire, 1000 Genomes: on the road to personalized medicine. Personalized Medicine, vol 5, isuue 3, pp. 195-197, 2008.

Cha M, Haddadi H, Benevenuto F, et al. Measuring User Influence in Twitter: The Million Follower Fallacy[C]. In: Proceedings of the Fourth International Conference on Weblogs and Social Media, Washington DC, USA. California : AAAI, 2010 : 10–17.

Chen Bo, Yu Ling, Liu Junting, Chu Weimin. Network public opinion communication control model in ubiquitous media environment [J]. System engineering theory and practice, 2011, 31 ( 11 ): 2140–2150.

Chen Yehua, Zhang Xiaoqian. Research on group emotion communication model and Simulation of Internet users in network emergencies [J]. Information science, 2018, 18 ( 7 ): 187–206.

D. Hanahan and R.A. Weinberg. The hallmarks of cancer. Cell, vol. 100, pp. 57-70, 2000.

Dalton WS, Friend SH. Cancer biomarkers-an invitation to the table. Science, vol. 312, pp 1165-1168, 2006.

European Public Health Alliance, www.epha.org http://www.epha.org

F. W. Frueh, PGx and BIOMARKERS: Current Role in Drug Development, U. S. Department of Health and Human Services, Food and Drug Administration (June 2005), http://www.fda.gov/cder/genomics/PGX-biomarkers.pdf.

Hu Yan, Chen Huayou. Network public opinion emergency group decision-making model based on three branch decision-making and prospect theory [J]. Journal of Anhui University (NATURAL SCIENCE EDITION), 2020, 44 ( 06 ): 13–19.

J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, P. Boyle, Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol, vol.18, pp. 581-92, 2007.

J. Hoh and J. Ott. Genetic dissection of diseases: design and methods. Curr. Opin. Gen. Dev., vol. 14, pp. 229-232, 2004.

JA. Ludwig, JN. Weinstein. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer, vol. 5, pp. 845- 856,2005.

JPA. loannidis, Is Molecular Profiling Ready for Use in Clinical Decision Making? The Oncologist, vol. 12, pp. 301-311, 2007.

K. H. Buetow, "Cyberinfrastructure: Empowering a "Third Way" in Biomedical Research", Science Magazine, vol. 308, no. 5723, pp. 821-824, 2005.

K. Yurkewicz, "Accelerating Cancer Research", Science Grid, June 21,2006. Available at http://www.interactions.org/sgtw/2006/0621/ cabigmore.html.

Life Sciences Informatics, UBS Warburg Market Report, 2005.

M. Cannataro, C. Comito, F. Lo Schiavo, and P. Veltri. Proteus, a Grid based Problem Solving Environment for Bioinformatics: Architecture and Experiments, IEEE Computational Intelligence Bulletin, vol.3, no.l, pp. 7-18, February 2004.

NL. Henry, DF. Hayes. Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer. The Oncologist, vol. 11, pp. 541-552, 2006.

Oliver S, Gao H, Fu Y. Situtio Analysis and Predictio of Web Public Sentimet[C]. Intemational Symposiumon Information Science and Engineering. IEEE, 2008 : 707–710.

S. Gutman, LG. Kessler. The US Food and Drug Administration perspective on cancer biomarker development. Nat Rev Cancer, vol. 6, pp. 565-571,2006.

Xiong F, Liu Y, Zhang Z. An information diffusion model based on retweeting mechanism for online social media[J]. Physics Letters A, 2012, 376 ( 30 ): 2103–2108.

Yang Dianqing, Han Qingyun. Fuzzy multi index comprehensive evaluation model of network public opinion situation level based on TOPSIS [J]. System science and mathematics, 2020, 40 ( 08 ): 1352–1364.

Yang Xiaoxi, Zheng Shanshan, Jin Zhaoyu, Xiong Siyue. Research on network public opinion early warning evaluation index system based on information ecology theory [J]. Information theory and practice : 1–10.

Zhang Silong, Wang Lancheng, Lou GuoZhe. Research on network public opinion research, judgment and early warning system based on information perception [J]. Information theory and practice: 1–10.

Zhou Shuyi, Zhu Hengmin, Wei Jing. Modeling and Simulation of network rumors and positive information interaction process [J]. Book and information, 2016, ( 6 ): 129–134.

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

Citra Ayuningtyas. (2026). Digital Transformation Framework Using Secure Distributed Platforms for Clinical Communities, Biomedical Industries, Drug Enterprises, and Public Users. Frontline Medical Sciences and Pharmaceutical Journal, 6(06), 36–41. Retrieved from https://www.frontlinejournals.org/journals/index.php/fmspj/article/view/978